Iwabuchi Y - Search Results

1

Long-Term Beneficial Effects of Tonsillectomy on Patients with Immunoglobulin A Nephropathy.

Moriyama T, Karasawa K, Miyabe Y, Akiyama K, Iwabuchi Y, Ogura S, Takabe T, Sugiura N, Seki M, Hanafusa N, Uchida K, Nitta K. Moriyama T, et al. Among authors: iwabuchi y. Kidney360. 2020 Sep 2;1(11):1270-1283. doi: 10.34067/KID.0003932020. eCollection 2020 Nov 25. Kidney360. 2020. PMID: 35372877 Free PMC article.

2

Primary IgA Vasculitis with Nephritis in a Patient with Rheumatoid Arthritis Diagnosed by Anti-galactose-deficient IgA1 Immunostaining.

Karasawa K, Iwabuchi Y, Kyoda M, Akihisa T, Yamaguchi E, Suzuki S, Ogura S, Takabe T, Miyabe Y, Kamiyama T, Nakano M, Manabe S, Kamiyama M, Akiyama K, Sato M, Uchida K, Nitta K, Moriyama T. Karasawa K, et al. Among authors: iwabuchi y. Intern Med. 2019 Sep 1;58(17):2551-2554. doi: 10.2169/internalmedicine.2640-19. Epub 2019 Jun 7. Intern Med. 2019. PMID: 31178497 Free PMC article.

3

Validation of the revised Oxford classification for IgA nephropathy considering treatment with corticosteroids/immunosuppressors.

Moriyama T, Karasawa K, Miyabe Y, Akiyama K, Ogura S, Takabe T, Sugiura N, Seki M, Iwabuchi Y, Uchida K, Nitta K. Moriyama T, et al. Among authors: iwabuchi y. Sci Rep. 2020 Jul 7;10(1):11151. doi: 10.1038/s41598-020-68087-y. Sci Rep. 2020. PMID: 32636449 Free PMC article.

4

Grading system utilising the total score of Oxford classification for predicting renal prognosis in IgA nephropathy.

Miyabe Y, Karasawa K, Akiyama K, Ogura S, Takabe T, Sugiura N, Seki M, Iwabuchi Y, Hanafusa N, Uchida K, Nitta K, Moriyama T. Miyabe Y, et al. Among authors: iwabuchi y. Sci Rep. 2021 Feb 11;11(1):3584. doi: 10.1038/s41598-021-82967-x. Sci Rep. 2021. PMID: 33574388 Free PMC article.

5

High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a.

Moriyama T, Itabashi M, Takei T, Kataoka H, Sato M, Shimizu A, Iwabuchi Y, Nishida M, Uchida K, Nitta K. Moriyama T, et al. Among authors: iwabuchi y. J Nephrol. 2015 Aug;28(4):451-6. doi: 10.1007/s40620-014-0154-0. Epub 2014 Oct 30. J Nephrol. 2015. PMID: 25355499

6

Long-term prognosis of adult patients with steroid-dependent minimal change nephrotic syndrome following rituximab treatment.

Iwabuchi Y, Takei T, Moriyama T, Itabashi M, Nitta K. Iwabuchi Y, et al. Medicine (Baltimore). 2014 Dec;93(29):e300. doi: 10.1097/MD.0000000000000300. Medicine (Baltimore). 2014. PMID: 25546674 Free PMC article.

7

Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome.

Miyabe Y, Takei T, Iwabuchi Y, Moriyama T, Nitta K. Miyabe Y, et al. Among authors: iwabuchi y. Clin Exp Nephrol. 2016 Feb;20(1):103-10. doi: 10.1007/s10157-015-1139-6. Epub 2015 Jul 3. Clin Exp Nephrol. 2016. PMID: 26138356

8

Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits.

Sato K, Makabe S, Iwabuchi Y, Kojima K, Sato M, Kataoka H, Moriyama T, Taneda S, Tsuchiya K, Nitta K, Mochizuki T. Sato K, et al. Among authors: iwabuchi y. Nephrology (Carlton). 2018 Aug;23(8):787-790. doi: 10.1111/nep.13261. Nephrology (Carlton). 2018. PMID: 29577510

9

Comparison of the response of frequently relapsing steroid-dependent minimal change nephrotic syndrome to rituximab therapy between childhood-onset and adult-onset disease.

Iwabuchi Y, Miyabe Y, Makabe S, Nakano M, Manabe S, Karasawa K, Moriyama T, Nitta K. Iwabuchi Y, et al. Medicine (Baltimore). 2018 Oct;97(42):e12704. doi: 10.1097/MD.0000000000012704. Medicine (Baltimore). 2018. PMID: 30334956 Free PMC article.

10

Successful Treatment with Belimumab in a Patient with Refractory Systemic Lupus Erythematosus after Initiation of Hemodialysis: Considering the Synergistic Effect of Belimumab and Immunological Burn-Out Phenomenon in End-Stage Renal Disease Patients on Hemodialysis.

Karasawa K, Ogura S, Takabe T, Miyabe Y, Iwabuchi Y, Akiyama K, Sato M, Moriyama T, Uchida K, Nitta K. Karasawa K, et al. Among authors: iwabuchi y. Blood Purif. 2022;51(2):182-188. doi: 10.1159/000512585. Epub 2021 Apr 23. Blood Purif. 2022. PMID: 33895749

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

242 results

Search Page